Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.

American journal of human genetics - 1 Sept 1999

Dørum A, Heimdal K, Hovig E, Inganäs M, Møller P

Abstract excerpt

For genetic counseling and predictive testing in families with inherited breast-ovarian cancer, penetrances and expressions of the underlying mutations should be known. We have previously reported two BRCA1 founder mutations in the Norwegian population. Index cases for the present study were found two different ways: through a series of consecutive ovarian cancers (n=16) and through our family cancer clinic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Codon, Terminator
Share to Founder Effect
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutagenesis, Insertional

Share to Norway

Share to Nuclear Family

Share to Ovarian Neoplasms

Share to Penetrance

Source

Open in PubMed Open full text

Identifiers

PMID: 10441573
DOI: 10.1086/302530
PMCID: PMC1377973

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.PMID 10441573Read ↗

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.Semantic proximity Read ↗

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA.Semantic proximity Read ↗

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.Semantic proximity Read ↗

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.Semantic proximity Read ↗

BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype.Semantic proximity Read ↗

BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.Semantic proximity Read ↗

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.Semantic proximity Read ↗

Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.Semantic proximity Read ↗

The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.Semantic proximity Read ↗

Tumour biological features of BRCA1-induced breast and ovarian cancer.Semantic proximity Read ↗

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.